Ligand Pharmaceuticals Inc

SWB:LGDN

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is LGDN's stock price target?

Price Target

236.14 EUR

According to Wall Street analysts, the average 1-year price target for LGDN is 236.14 EUR with a low forecast of 208.42 EUR and a high forecast of 289.48 EUR.

What is the Revenue forecast for Ligand Pharmaceuticals Inc?

Projected CAGR

16%

Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 16%.

What is the Gross Profit forecast for Ligand Pharmaceuticals Inc?

Projected CAGR

17%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 7 years is 17%.

What is the Operating Income forecast for Ligand Pharmaceuticals Inc?

Projected CAGR

34%

Over the last 14 years, the compound annual growth rate for Operating Income has been 26%. The projected CAGR for the next 8 years is 34%.

What is the Pre-Tax Income forecast for Ligand Pharmaceuticals Inc?

Projected CAGR

24%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 24%.

What is the Net Income forecast for Ligand Pharmaceuticals Inc?

Projected CAGR

26%

Over the last 14 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 7 years is 26%.